Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 3, 2013, Pages 443-451

  He, Yonggang ^a   Gong, Yilei ^a   Lin, Jie ^a   Chang, David W ^a   Gu, Jian ^a   Roth, Jack A ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA H2AX PROTEIN; HISTONE H2AX; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; IONIZING RADIATION; LASER SCANNING CYTOMETRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA DAMAGE; DNA REPAIR; FEMALE; FOLLOW-UP STUDIES; HISTONES; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; PROGNOSIS; RADIATION, IONIZING; RISK FACTORS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84876544165     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0794     Document Type: Article

References (55)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Villeneuve PJ, Mao Y. Lifetime probability of developing lung cancer, by smoking status, Canada. Can J Public Health 1994;85:385-8.
3. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008;123:1-7. (Pubitemid 351705185)
4. Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010;11:321-30.
5. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43:403-9. (Pubitemid 19092320)
6. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 1989;49:4626-8. (Pubitemid 19208371)
7. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007;67:3493-5. (Pubitemid 46762125)
8. Ishida R, Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res 1982;42:4000-6. (Pubitemid 13198555)
9. Futaki M, Liu JM. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol Med 2001;7: 560-5. (Pubitemid 33127142)
10. Kupfer GM, Näf D, D'Andrea AD. Molecular biology of Fanconi anemia. Hematol Oncol Clin North Am 1997;11:1045-60. (Pubitemid 28028690)
11. Jeggo PA, Carr AM, Lehmann AR. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet 1998;14: 312-6. (Pubitemid 28378268)
12. Berneburg M, Lehmann AR. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 2001; 43:71-102. (Pubitemid 33804435)
13. Hsu TC, Spitz MR, Schantz SP. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1991;1:83-9.
14. Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, et al. Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk. Int J Cancer 2007;120:2687-95. (Pubitemid 46651292)
15. Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang ZF, Tobi H, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:530-5. (Pubitemid 26118723)
16. Strom SS,WuS, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, et al. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr 1995:29-33.
17. Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, et al. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis 2003;24:269-74. (Pubitemid 36267096)
18. Gu J, Horikawa Y, Chen M, Dinney CP, Wu X. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2445-50.
19. Masuda A, Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 2002;21:6884-97. (Pubitemid 35221935)
20. Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 2003;194:77-95. (Pubitemid 36886430)
21. Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 2000;405:697-700. (Pubitemid 30428657)
22. Misteli T, Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol 2009; 10:243-54.
23. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 2002; 12:162-9. (Pubitemid 34219488)
24. Huen MS, Chen J. The DNA damage response pathways: at the crossroad of protein modifications. Cell Res 2008;18:8-16.
25. Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A 2003;100:5057-62. (Pubitemid 36542657)
26. Ismail IH, Wadhra TI, Hammarsten O. An optimized method for detecting gamma-H2AX in blood cells reveals a significant interindividual variation in the gamma-H2AX response among humans. Nucleic Acids Res 2007;35:e36.
27. Banath JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 2004;64:7144-9. (Pubitemid 39331029)
28. Sedelnikova OA, Pilch DR, Redon C, Bonner WM. Histone H2AX in DNA damage and repair. Cancer Biol Ther 2003;2:233-5.
29. Lobrich M, Rief N, Kuhne M, Heckmann M, Fleckenstein J, Rube C, et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci U S A 2005;102:8984-9. (Pubitemid 40881065)
30. Sedelnikova OA, Horikawa I, Redon C, Nakamura A, Zimonjic DB, Popescu NC, et al. Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell 2008;7:89-100.
31. Redon CE, Nakamura AJ, Zhang YW, Ji JJ, Bonner WM, Kinders RJ, et al. Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin Cancer Res 2010;16:4532-42.
32. Kinders RJ, Hollingshead M, Lawrence S, Ji J, Tabb B, Bonner WM, et al. Development of a validated immunofluorescence assay for gammaH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity. Clin Cancer Res 2010;16:5447-57.
33. BonnerWM, RedonCE,DickeyJS,NakamuraAJ, SedelnikovaOA, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer 2008;8:957-67.
34. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99: 715-26. (Pubitemid 47073532)
35. Andrievski A, Wilkins RC. The response of gamma-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures. Int J Radiat Biol 2009;85:369-76.
36. Kassie F, Parzefall W, Knasmuller S. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies. Mutat Res 2000;463:13-31. (Pubitemid 30326798)
37. Colleu-Durel S, Guitton N, Nourgalieva K, Legue F, Leveque J, Danic B, et al. Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 2004;40:445-51. (Pubitemid 38121283)
38. Wang J, Delgado DA, Deen DF. Use of pulsed-field gel electrophoresis to investigate factors influencing the measurement of DNA doublestrand breaks in human brain tumour specimens. Int J Radiat Biol 1995;67:153-60.
39. Prise KM, Ahnstrom G, Belli M, Carlsson J, Frankenberg D, Kiefer J, et al. A review of dsb induction data for varying quality radiations. Int J Radiat Biol 1998;74:173-84. (Pubitemid 28372545)
40. Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, et al. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 2005;65:349-57. (Pubitemid 40070828)
41. Berwick M, Vineis P. Markers ofDNArepair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92: 874-97. (Pubitemid 30429188)
42. Hamasaki K, Imai K, Nakachi K, Takahashi N, Kodama Y, Kusunoki Y. Short-term culture and gammaH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes. Environ Mol Mutagen 2007;48:38-47. (Pubitemid 46238557)
43. Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. Prolonged expression of the gamma-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer 2011;129:2928-34.
44. MacPhail SH, Banath JP, Yu TY, Chu EH, Lambur H, Olive PL. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 2003;79:351-8. (Pubitemid 36920536)
45. Wu X, Delclos GL, Annegers JF, Bondy ML, Honn SE, Henry B, et al. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995;4:583-8.
46. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 1995;4:99-103.
47. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011;12:399-408.
48. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009;458:719-24.
49. Chao DL, Maley CC,Wu X, Farrow DC, Galipeau PC, Sanchez CA, et al. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1935-40. (Pubitemid 44664271)
50. Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, et al. Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis 2011;32:69-73.
51. Boffetta P, Jarvholm B, Brennan P, Nyren O. Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer 2001;94:591-3.
52. Wu X, Yu H, Amos CI, Hong WK, Spitz MR. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst 2000;92:737-43. (Pubitemid 30365534)
53. Cloos J, Nieuwenhuis EJ, Boomsma DI, Kuik DJ, van der Sterre ML, Arwert F, et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst 1999;91:1125-30. (Pubitemid 29330550)
54. Roberts SA, Spreadborough AR, Bulman B, Barber JB, Evans DG, Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 1999;65:784-94. (Pubitemid 30468725)
55. WuX, Spitz MR, Amos CI, Lin J, Shao L, Gu J, et al. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res 2006; 66:5993-6.